文献速递免疫规划妇幼与学校卫生

既往流感病毒疫苗接种对母体抗体应答的影响:对实现新生儿保护的意义

Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
PubMed 文献 · Vaccine · 2017-08-01

本研究在美国141名孕妇中检测四价流感疫苗接种前、接种后30天及分娩时母血与脐血的血凝抑制抗体滴度,比较上一年度接种与未接种者的抗体水平、血清保护和血清转化。既往接种者基线抗体较高,但接种后1个月抗体应答和血清转化较低;分娩时母亲和新生儿的抗体滴度及血清保护率无显著差异。

要点

  • 既往接种者基线抗体滴度和/或血清保护率较高,但接种后1个月抗体应答和血清转化率较低。
  • 分娩时母亲和新生儿的抗体滴度及血清保护率无显著差异。
  • 脐血与母体抗体滴度比值反映的抗体转移效率无有意义的差异。

核心结论

  • 在上一年度接种流感疫苗的孕妇中,基线抗体滴度较高,但接种后1个月对全部流感毒株的抗体应答降低。
  • 既往母体接种未显著影响分娩时母体抗体水平或转移至新生儿的抗体水平。

研究设计与样本

  • 在美国141名孕妇队列中,通过血凝抑制试验测量接种四价流感疫苗前、接种后30天及分娩时(母血和脐血)的流感抗体滴度。
  • 采用逻辑回归分析比较上一年度接种与未接种孕妇的HAI滴度、血清保护和血清转化,并校正年龄、BMI、产次、接种时孕周和接种年份。

主要发现

  • 与上一年度未接种者(n=50)相比,既往接种者(n=91)在校正协变量后对全部四种毒株的基线抗体滴度和/或血清保护率较高。
  • 既往接种还预测接种后1个月抗体应答和血清转化率较低。
  • 分娩时,母亲或新生儿的抗体滴度或血清保护率无显著差异,脐血与母体抗体滴度比值所反映的抗体转移效率无有意义的差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the US, influenza vaccination is recommended annually to everyone ≥6months. Prior receipt of influenza vaccine can dampen antibody responses to subsequent vaccination. This may have implications for pregnant women and their newborns, groups at high risk for complications from influenza infection. OBJECTIVE: This study examined effects of prior vaccination on maternal and cord blood antibody levels in a cohort of pregnant women in the US. STUDY DESIGN: Influenza antibody titers were measured in 141 pregnant women via the hemagglutination inhibition (HAI) assay prior to receipt of quadrivalent influenza vaccine, 30days post-vaccination, and at delivery (maternal and cord blood). Logistic regression analyses adjusting for age, BMI, parity, gestational age at vaccination, and year of vaccination compared HAI titers, seroprotection, and seroconversion in women with versus without vaccination in the prior year. RESULTS: Compared to those without vaccination in the previous year (n=50), women with prior vaccination (n=91) exhibited higher baseline antibody titers and/or seroprotection rates against all four strains after controlling for covariates. Prior vaccination also predicted lower antibody responses and seroconversion rates at one month post-vaccination. However, at delivery, there were no significant differences in antibody titers or seroprotection rates in women or newborns, and no meaningful differences in the efficiency of antibody transfer, as indicated by the ratio of cord blood to maternal antibody titers at the time of delivery. CONCLUSION: In this cohort of pregnant women, receipt of influenza vaccine the previous year predicted higher baseline antibody titers and decreased antibody responses at one month post-vaccination against all influenza strains. However, prior maternal vaccination did not significantly affect either maternal antibody levels at delivery or antibody levels transferred to the neonate. This study is registered with the NIH as a clinical trial (NCT02148874).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Christian LM, Beverly C, Mitchell AM, et al. Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns. Vaccine. 2017. PMID: 28778612. doi:10.1016/j.vaccine.2017.05.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。